Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion

Histone methyltransferase SETDB1 is required for prostate cancer cell proliferation, migration and invasion

SETDB1 has been established as an oncogene in a number of human carcinomas. The present study was to evaluate the expression of SETDB1 in prostate cancer (PCa) tissues and cells and to preliminarily investigate the role of SETDB1 in prostate tumorigenesis in vitro. Quantitative reverse transcription...

Full description

Bibliographic Details
Main Authors:	Yi Sun, Min Wei, Shan-Cheng Ren, Rui Chen, Wei-Dong Xu, Fu-Bo Wang, Ji Lu, Jian Shen, Yong-Wei Yu, Jian-Guo Hou, Chuan-Liang Xu, Jiao-Ti Huang, Ying-Hao Sun
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2014-04-01
Series:	Asian Journal of Andrology
Subjects:	epigenomics; histone methyltransferases; prostate cancer (PCa); SETDB1
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2014;volume=16;issue=2;spage=319;epage=324;aulast=Sun

Similar Items

The Updating of Biological Functions of Methyltransferase SETDB1 and Its Relevance in Lung Cancer and Mesothelioma
by: Li Yuan, et al.
Published: (2021-07-01)

Structure, Activity and Function of the SETDB1 Protein Methyltransferase
by: Mariam Markouli, et al.
Published: (2021-08-01)

The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease
by: Hanshen Luo, et al.
Published: (2023-12-01)

Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma
by: Yuqin Zhang, et al.
Published: (2018-05-01)

Evidence of a synthetic lethality interaction between SETDB1 histone methyltransferase and CHD4 chromatin remodeling protein in a triple negative breast cancer cell line
by: M.S. Moraes-Almeida, et al.
Published: (2023-11-01)

Role of histone methyltransferase SETDB1 in regulation of tumourigenesis and immune response
by: Zhipeng Zhao, et al.
Published: (2022-12-01)

Methyltransferase Setdb1 Promotes Osteoblast Proliferation by Epigenetically Silencing Macrod2 with the Assistance of Atf7ip
by: Lijun Zhang, et al.
Published: (2022-08-01)

Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma
by: Guangda Yuan, et al.
Published: (2023-03-01)

Oncogenic Roles Of A Histone Methyltransferase SETDB2 In AML1-ETO Positive AML
by: Mu G, et al.
Published: (2020-02-01)

Expression of the Major and Pro-Oncogenic H3K9 Lysine Methyltransferase SETDB1 in Non-Small Cell Lung Cancer
by: Paola Cruz-Tapias, et al.
Published: (2019-08-01)

SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization
by: Maria João Ferreira, et al.
Published: (2017-12-01)

SETDB2 interacts with BUBR1 to induce accurate chromosome segregation independently of its histone methyltransferase activity
by: Yanhong Tu, et al.
Published: (2024-03-01)

ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex
by: Richard T. Timms, et al.
Published: (2016-10-01)

TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway
by: Hongyu Gu, et al.
Published: (2022-09-01)

Histone methyltransferase and drug resistance in cancers
by: Cheng Yang, et al.
Published: (2020-08-01)

The Histone Methyltransferase SETDB1 Modulates Survival of Spermatogonial Stem/Progenitor Cells Through NADPH Oxidase
by: Xueliang Li, et al.
Published: (2020-10-01)

Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks
by: Guillermo Urrutia, et al.
Published: (2021-06-01)

Targets of histone H3 lysine 9 methyltransferases
by: Aidan J. Levinsky, et al.
Published: (2022-12-01)

Emerging roles of H3K9me3, SETDB1 and SETDB2 in therapy-induced cellular reprogramming
by: Joachim Torrano, et al.
Published: (2019-03-01)

Histone Methyltransferases SUV39H1 and G9a and DNA Methyltransferase DNMT1 in Penumbra Neurons and Astrocytes after Photothrombotic Stroke
by: Svetlana Sharifulina, et al.
Published: (2021-11-01)

Histone Methyltransferases as Therapeutic Targets for Kidney Diseases
by: Chao Yu, et al.
Published: (2019-12-01)

Arabidopsis Histone Methyltransferase SUVH5 Is a Positive Regulator of Light-Mediated Seed Germination
by: Dachuan Gu, et al.
Published: (2019-06-01)

Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
by: Melanie A. Whitmore, et al.
Published: (2022-04-01)

SETDB1-Mediated Silencing of Retroelements
by: Kei Fukuda, et al.
Published: (2020-05-01)

Enhanced Cytotoxic Effects in Human Oral Squamous Cell Carcinoma Cells Treated with Combined Methyltransferase Inhibitors and Histone Deacetylase Inhibitors
by: Ryosuke Ushio, et al.
Published: (2022-03-01)

Epigenetic Deregulation of the Histone Methyltransferase KMT5B Contributes to Malignant Transformation in Glioblastoma
by: Virginia López, et al.
Published: (2021-08-01)

Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
by: Olivier Binda
Published: (2020-02-01)

SETDB1 Methylates MCT1 Promoting Tumor Progression by Enhancing the Lactate Shuttle
by: Xiaowei She, et al.
Published: (2023-10-01)

The role of histone methyltransferases in neurocognitive disorders associated with brain size abnormalities
by: Foster D. Ritchie, et al.
Published: (2023-02-01)

Enhanced expression of endogenous retroviruses and of TRIM28 and SETDB1 in children with food allergy
by: Pier‐Angelo Tovo, et al.
Published: (2022-03-01)

Impact of Histone Lysine Methyltransferase SUV4-20H2 on Cancer Onset and Progression with Therapeutic Potential
by: Stela Papadaki, et al.
Published: (2024-02-01)

The Roles of Histone Lysine Methyltransferases in Heart Development and Disease
by: Jun-yi Zhu, et al.
Published: (2023-07-01)

SETDB1 promotes glioblastoma growth via CSF-1-dependent macrophage recruitment by activating the AKT/mTOR signaling pathway
by: Shuai Han, et al.
Published: (2020-10-01)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
by: Zexuan Liu, et al.
Published: (2022-04-01)

The Indispensable Role of Histone Methyltransferase PoDot1 in Extracellular Glycoside Hydrolase Biosynthesis of Penicillium oxalicum
by: Yanan Li, et al.
Published: (2019-11-01)

Role and potential therapeutic value of histone methyltransferases in drug resistance mechanisms in lung cancer
by: Linxiang Zhang, et al.
Published: (2024-03-01)

SETDB-1: A Potential Epigenetic Regulator in Breast Cancer Metastasis
by: Jacob Batham, et al.
Published: (2019-08-01)

Unique Role of Histone Methyltransferase PRDM8 in the Tumorigenesis of Virus-Negative Merkel Cell Carcinoma
by: Elias Orouji, et al.
Published: (2020-04-01)

Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington’s disease mouse model
by: Yu Jin Hwang, et al.
Published: (2021-01-01)

Histone H3K4 Methyltransferases as Targets for Drug-Resistant Cancers
by: Liu Yang, et al.
Published: (2021-06-01)